e-Profile Login and ID Quick Search
Counterfeit Phentermine HCI Tablets Found in United States
Actavis Elizabeth LLC is warning consumers and health care providers that counterfeit phentermine HCl Tablets (USP 37.5 mg) that contain fenfluramine, a dangerous ingredient, have been found in the US. The manufacturer explains in a press release that phentermine is an appetite suppressant medicine that Actavis has not distributed in the US since 2008. Further, Actavis does not intend to market phentermine HCL Tablets (USP 37.5 mg) until at least 2012, and Actavis does not distribute phentermine to online sellers. For these reasons, any product sold in the US today reporting to be Actavis' phentermine HCl Tablets (USP 37.5 mg) is counterfeit. Actavis advises that the counterfeit tablets are a white oval-shaped bisected tablet with blue speckles with an "A" and "159" embossed on the tablet. The counterfeit tablets contain fenfluramine, which was withdrawn from the US market in 1997 because it can cause heart damage, known as valvular heart disease. Actavis advises that anyone who has the counterfeit version should stop taking the product, and they are encouraged to make a report on any adverse events or side effects that may be related to the use of this product to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program using the online form or by following the FDA instructions for submitting by fax or mail.
